About
Mannkind Corp (NASDAQ:MNKD) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 9 2026
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
Mar 5 2026
MannKind Announces Settlement of Convertible Senior Notes
Mar 4 2026
MannKind to Participate in Upcoming Investor Conferences
Feb 26 2026
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 19 2026
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Financials
Revenue
$348.97 M
Market Cap
$770.25 M
P/E Ratio
125.00
EPS
0.02
Google Übersetzer